Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the fiscal year ending June 20, 2022. The company expects net sales to be JPY 160,000 million, Operating income to be JPY 6,500 million, net income attributable to owners of parent to be JPY 4,720 million or JPY 310.99 per basic share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,782 JPY | -3.47% |
|
+1.57% | +1.90% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.90% | 544M | |
-55.94% | 10.44B | |
-45.65% | 8.68B | |
-26.18% | 6.45B | |
-7.09% | 5.98B | |
+85.61% | 4.91B | |
-4.09% | 4.57B | |
+5.73% | 4.49B | |
-23.25% | 4.1B | |
-19.42% | 2.58B |
- Stock Market
- Equities
- 9267 Stock
- News Genky DrugStores Co., Ltd.
- Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2022